Adverse drug reaction signals mining of three immunomodulatory drugs based on real-world data
10.13699/j.cnki.1001-6821.2024.06.026
- VernacularTitle:基于真实世界数据的3种免疫调节药药品不良反应信号挖掘研究
- Author:
Zheng CAI
1
;
Peng MEN
;
Zai-Wei SONG
;
Rong-Sheng ZHAO
Author Information
1. 北京大学第三医院药剂科,北京 100191
- Keywords:
thalidomide;
lenalidomide;
pomalidomide;
safety;
real-world data
- From:
The Chinese Journal of Clinical Pharmacology
2024;40(6):909-913
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the postmarketing safety characteristics of three immunomodulatory drugs(IMiDs)(thalidomide,lenalidomide and pomalidomide)in order to provide reference for clinical rational drug use.Methods The Open Vigil 2.0 tool was used to collect adverse drug event(ADE)reporting data from the U.S.Food and Drug Administration's(FDA)Adverse Event Reporting System(FAERS)between the first quarter of 2013 and the second quarter of 2022 for three IMiDs as primary suspect drugs.High frequency ADE was analyzed by mapping according to Medical Dictionary for Regulatory Activities(MedDRA terminology)25.0.The effective signals of adverse drug reactions(ADR)were screened according to the reporting odds ratio(ROR)and proportional reporting ratio(PRR)methods,and the high-intensity signals were analyzed.Results Among the top 20 ADEs,peripheral neuropathy,decreased blood count,thrombosis,skin squamous cell carcinoma and other ADEs occurred in all three drugs,but the distribution of the involved tissues and organs was different.Among the top 20 ADR signals,nearly half of the ADR signals of the 3 drugs were also in the high-frequency ADE range,among which 3 drugs showed increased human chorionic gonadotrophin,thalidomide and lenalidomide showed false positives in pregnancy tests,rectal adenocarcinoma and colorectal adenocarcinoma,and pomalidomide and lenalidomide showed decreased complete blood counts.Conclusion The overall ADE distribution of the three diamines is consistent,but there are some differences in the specific ADR signal characteristics.In clinical application,more attention should be paid to hemocytopenia,peripheral neuropathy,thrombus and second primary malignant tumors.
